Archive:
Aug 21, 2025, 12:00 AM
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy by enhancing anti-tumor immune responses, yet their use can lead to immune-related adverse events (irAE), including neurological c…
Solid phase micro extraction of volatile organic compounds (VOC) shows promise for future study of V
Introduction: Skin cancer sites are known to release volatile organic compounds (VOCs) and these compounds can be collected and analysed to aid in the chemical profiling of skin cancers. Patients an…